106 related articles for article (PubMed ID: 1726461)
1. Association of high sensitization to the structure of HLA class I alleles.
Clark BD; Geer LI; Park MS; Terasaki PI
Clin Transpl; 1991; ():347-62. PubMed ID: 1726461
[TBL] [Abstract][Full Text] [Related]
2. HLA class I epitopes accounted for by single residues.
Park MS; Clark BD; Maruya E; Terasaki PI
Clin Transpl; 1991; ():335-45. PubMed ID: 1726460
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation.
Laundy GJ; Bradley BA
Transplantation; 1995 Apr; 59(8):1207-13. PubMed ID: 7537397
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
El-Awar NR; Akaza T; Terasaki PI; Nguyen A
Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
[TBL] [Abstract][Full Text] [Related]
5. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
[TBL] [Abstract][Full Text] [Related]
6. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
Duquesnoy RJ; Marrari M
Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
[TBL] [Abstract][Full Text] [Related]
7. HLA epitopes detected by serology.
Park MS; Barbetti AA; Geer LI; Clark BD; Terasaki PI; Aoki J
Clin Transpl; 1990; ():515-31. PubMed ID: 1715741
[TBL] [Abstract][Full Text] [Related]
8. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
9. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30.
Kato K; Trapani JA; Allopenna J; Dupont B; Yang SY
J Immunol; 1989 Nov; 143(10):3371-8. PubMed ID: 2478623
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
12. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
El-Awar N; Lee JH; Tarsitani C; Terasaki PI
Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
[TBL] [Abstract][Full Text] [Related]
13. HLA amino acid residue matching.
Takemoto SK
Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
[TBL] [Abstract][Full Text] [Related]
14. Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.
Hildebrand WH; Madrigal JA; Belich MP; Zemmour J; Ward FE; Williams RC; Parham P
J Immunol; 1992 Dec; 149(11):3563-8. PubMed ID: 1385528
[TBL] [Abstract][Full Text] [Related]
15. Description of novel class I alleles encountered during routine registry typing in 2007.
Lazaro AM; Xiao Y; Masaberg C; Nichol L; Ivaskova E; Banwart R; Field E; Ng J; Hurley CK; Posch PE
Tissue Antigens; 2009 Sep; 74(3):238-40. PubMed ID: 19523144
[TBL] [Abstract][Full Text] [Related]
16. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens.
El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A
Clin Transpl; 2007; ():175-94. PubMed ID: 18637469
[TBL] [Abstract][Full Text] [Related]
17. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
18. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.
Toubert A; Raffoux C; Boretto J; Sire J; Sodoyer R; Thurau SR; Amor B; Colombani J; Lemonnier FA; Jordan BR
J Immunol; 1988 Oct; 141(7):2503-9. PubMed ID: 2459214
[TBL] [Abstract][Full Text] [Related]
20. The impact of HLA-A matching in corneal transplantation.
Munkhbat B; Hagihara M; Shimazaki J; Kanai N; Morita N; Gansuvd B; Kato S; Tsubota K; Tsuji K
Tokai J Exp Clin Med; 1999 Jun; 24(2):63-71. PubMed ID: 10641994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
